Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
Real-world utilization of pembrolizumab dosing schedules in Belgium: a multi-center retrospective study using a common data model and natural language processing
Annelies Verbiest
,
Hans Prenen
,
Annelies Janssens
,
Christof Vulsteke
,
Danielle Delombaerde
,
Laura Tack
,
Philip R Debruyne
,
Iege Bassez
,
Clara L Oeste
,
Agnes Brandtmüller
,
Carl Baxter
,
Pieterjan Debie
, and
Jan Vertriest
Journal of Comparative Effectiveness Research
21 Oct 2026
Comparative cost analysis of Eluvia™ versus Zilver
®
PTX
®
in treating femoropopliteal peripheral artery disease utilizing real-world data
Elizabeth A Genovese
,
Abimbola O Williams
,
Ryoko Sato
,
Alysha M McGovern
, and
Michael R Jaff
Journal of Comparative Effectiveness Research
21 Oct 2026
EURORDIS publishes European Blueprint for EU Action Plan on Rare Diseases
The Evidence Base
21 Oct 2026
DIA’s 2026 Real-World Evidence Conference daily round-ups: Day 2
The Evidence Base
21 Oct 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
21 Oct 2026
EURORDIS publishes European Blueprint for EU Action Plan on Rare Diseases
21 Oct 2026
DIA’s 2026 Real-World Evidence Conference daily round-ups: Day 2
20 Oct 2026
DIA’s 2026 Real-World Evidence Conference daily round-ups: Day 1
21 Oct 2026
DIA’s 2026 Real-World Evidence Conference daily round-ups: Day 2
19 Oct 2026
The methods were never the problem: Mark Sculpher on politics, opportunity cost and the future of HTA
16 Oct 2026
World Orphan Drug Congress Europe 2026: Previewing the discussions on evidence, HTA and access
19 Oct 2026
Event preview: 14th IMPACCT Real-World Evidence Summit
19 Oct 2026
The methods were never the problem: Mark Sculpher on politics, opportunity cost and the future of HTA
12 Oct 2026
Moving the finish line for HEOR: Rob Abbott on closing the gap between science and decisions
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
21 Oct 2026
EURORDIS publishes European Blueprint for EU Action Plan on Rare Diseases
21 Oct 2026
DIA’s 2026 Real-World Evidence Conference daily round-ups: Day 2
20 Oct 2026
DIA’s 2026 Real-World Evidence Conference daily round-ups: Day 1
19 Oct 2026
Event preview: 14th IMPACCT Real-World Evidence Summit
.png)
.png)
